Evidence map›Paper›PMID 30754675›Full record

ArticleInternational journal of environmental research and public health2019

Exploring Drug-Related Problems in Diabetic Patients during Ramadan Fasting in Saudi Arabia: A Mixed-Methods Study.

Waleed Saleh Alluqmani, Mohammed Misri Alotaibi, Waleed Jamal Almalki, Abdulrahman Althaqafi, Hamed Abdullah Alawi, Fahad Althobiani, Amjad Abdullah Albishi, Amjad Ahmad Madkhali, Layal Yahia Baunes, Razan Ibrahim Alhazmi and 4 more

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Safety and tolerability of Empagliflozin use during the holy month of Ramadan by fasting patients with type 2 diabetes: A prospective cohort study.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Waleed Saleh AlluqmaniCollege of Pharmacy, Umm al-Qura University, Taif Road, Makkah 24381, Saudi Arabia. waleed9055@hotmail.com.
Mohammed Misri AlotaibiCollege of Pharmacy, Umm al-Qura University, Taif Road, Makkah 24381, Saudi Arabia. momsmf@hotmail.com.
Waleed Jamal AlmalkiCollege of Pharmacy, Umm al-Qura University, Taif Road, Makkah 24381, Saudi Arabia. ph.waleed.ja@gmail.com.
Abdulrahman AlthaqafiCollege of Pharmacy, Umm al-Qura University, Taif Road, Makkah 24381, Saudi Arabia. abdulrhmanthaqafi@gmail.com.
Hamed Abdullah AlawiCollege of Pharmacy, Umm al-Qura University, Taif Road, Makkah 24381, Saudi Arabia. hamed234@windowslive.com.
Fahad AlthobianiCollege of Pharmacy, Umm al-Qura University, Taif Road, Makkah 24381, Saudi Arabia. fahaddakilallh@gmail.com.
Amjad Abdullah AlbishiCollege of Pharmacy, Umm al-Qura University, Taif Road, Makkah 24381, Saudi Arabia. ph-jad@hotmail.com.
Amjad Ahmad MadkhaliCollege of Pharmacy, Umm al-Qura University, Taif Road, Makkah 24381, Saudi Arabia. ph.amjaad@hotmail.com.
Layal Yahia BaunesCollege of Pharmacy, Umm al-Qura University, Taif Road, Makkah 24381, Saudi Arabia. laaayaly-2009@windowslive.com.
Razan Ibrahim AlhazmiCollege of Pharmacy, Umm al-Qura University, Taif Road, Makkah 24381, Saudi Arabia. razxhr@gmail.com.
Elaf Mohammed DomanCollege of Pharmacy, Umm al-Qura University, Taif Road, Makkah 24381, Saudi Arabia. e_m_h_d@hotmail.com.
Anwar Hussain AlhazmiCollege of Pharmacy, Umm al-Qura University, Taif Road, Makkah 24381, Saudi Arabia. alhazmi.anwar.h@gmail.com.
Majid AliCollege of Pharmacy, Umm al-Qura University, Taif Road, Makkah 24381, Saudi Arabia. majid.ali@hotmail.com.
Ejaz CheemaCollege of Pharmacy, Umm al-Qura University, Taif Road, Makkah 24381, Saudi Arabia. E.Cheema@bham.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to identify any drug-related problems (DRPs) in diabetic patients during Ramadan fasting in Saudi Arabia. The study used a mixed-methods approach consisting of two phases and was conducted in Makkah, Saudi Arabia from December 2017 to March 2018. The first phase of the study involved qualitative semi-structured individual interviews with diabetic patients. A 13-item questionnaire was used in the second phase to further identify DRPs in the wider population. The data was mainly presented as frequencies and percentages. Inferential statistics was performed using Statistical Package for Social Sciences (SPSS) version 21 to compare relevant variables/questions using the chi-square test. Twenty patients (10 male, 10 female) attended face-to-face interviews during the first phase of the study while 95 (40 male, 55 female) completed the questionnaire in the second phase of the study. Two possible risk factors for DRPs were identified from the qualitative data: patient-related factors, including changes in their medicine intake during fasting, and healthcare professionals-related factors, including lack of advice from healthcare professionals regarding fasting. The quantitative results indicated that 52 (54%) of the 95 participants who observed fasting reported to have changed the way they were taking their medicines. Furthermore, 41% of the participants experienced general healthcare problems such as hypoglycemia, hyperglycemia, fatigue, excessive sweating, and gastrointestinal disturbances. Healthcare professionals need to educate patients who are at risk of DRPs by providing structured education and counseling.

Indexed as

FastingIslamAdultDiabetes ComplicationsDiabetes MellitusFemaleHumansHyperglycemiaHypoglycemiaHypoglycemic AgentsInterviews as TopicMaleMiddle AgedSaudi ArabiaSurveys and QuestionnairesHypoglycemic AgentsdiabetesfastingmedicinesRamadan

Identifiers

PMID30754675
PMCPMC6388163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.